2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ

2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ°¡ 8¿ù 19ÀÏ(±Ý), 20ÀÏ(Åä) ¾çÀÏ°£ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÄÁº¥¼Ç¼¾ÅÍ¿¡¼­ °³ÃֵǾú´Ù.

¿ÃÇطΠ⸳ 14ÁÖ³âÀ» ¸ÂÀº ¿ì¸® ÇÐȸ´Â Äڷγª ½Ã±¹¿¡ µû¶ó ¿Â¿ÀÇÁ ÇÏÀ̺긮µå ¹æ½ÄÀ¸·Î Çмú´ëȸ¸¦ ÁøÇàÇÏ¿´À¸³ª °¢ ºÐ¾ß º° ¸¹Àº ȸ¿øµéÀÌ Á÷Á¢ ÇÐȸÀåÀ» ã¾Æ ¼ºÈ²À» ÀÌ·ç¾úÀ¸¸ç ¶æ ±íÀº Çмú ±³·ù¿Í Ä£¸ñÀÇ ½Ã°£À» °¡Á³´Ù.

À̹ø Çмú´ëȸ °³ÃÖ ´çÀÏ¿¡´Â º°µµ Çù·Â ¼¼¼ÇÀ» ÅëÇÏ¿© °©»ó¼±¾Ï ȯÀÚÀÇ ¼ö¼ú ÀÌÈÄ »îÀÇ Áú ¹× °Ç°­ °á°ú¿¡ ´ëÇÑ PACEN (ȯÀÚÁß½ÉÀÇ·á±â¼úÃÖÀûÈ­»ç¾÷´Ü)°úÀÇ °øµ¿¿¬±¸ °á°ú ¹ßÇ¥ ¹× Åä·Ðȸ°¡ ÀÖ¾úÀ¸¸ç Åä·Ðȸ Á÷ÈÄ ¾ð·Ð»ç ´ë»óÀÇ ±âÀÚ °£´ãȸ¸¦ °³ÃÖÇÏ¿´´Ù. °­È£Ã¶(Àü³²ÀÇ´ë ³»°ú) ÀÌ»çÀå ¹× ¹Ú¿µÁÖ(¼­¿ïÀÇ´ë ³»°ú) ±³¼ö, PACEN PMÀ» ¸Ã°í ÀÖ´Â ¼ÛÀç°ü(¿ï»êÀÇ´ë ³»°ú) ±³¼ö, ±è¹ÎÁ¤ PACEN »ç¹«±¹ÀåÀÌ Á÷Á¢ ±âÀÚµé°ú ÁúÀÇ ÀÀ´äÀÇ ½Ã°£À» °¡Á³À¸¸ç ¿ì¸® ÇÐȸ°¡ ÁøÇà ÁßÀÎ °©»ó¼± °áÀý ¹× ¾Ï, ÀӽźΠ°©»ó¼±Áúȯ¿¡ ´ëÇÑ Áø·á ±Ç°í¾È °³Á¤¾È¿¡ ´ëÇÏ¿© È«º¸ÇÏ°í ´ëÇÑ°©»ó¼±ÇÐȸ-PACEN °øµ¿ ¿¬±¸¸¦ ¼Ò°³ÇÏ°í Áß°£ °á°ú¸¦ ¹ßÇ¥ÇÏ´Â ±âȸ¸¦ °¡Á³´Ù.

ÀúÀ§Ç豺 °©»ó¼±¾ÏÀÇ Áø´Ü°ú Ä¡·á¿¡ ´ëÇÑ »çȸÀû À̽´°¡ Áö¼ÓÀûÀ¸·Î ´ëµÎµÇ´Â »óȲ¿¡¼­ ÇÐȸ°¡ ÁÖµµÀûÀ¸·Î ÀÓ»óÀü¹®°¡¿Í ȯÀÚ¿¡°Ô ¿Ã¹Ù¸¥ Á¤º¸¸¦ Á¦°øÇÏ°í ÁöħÀ» ¸¶·ÃÇϱâ À§ÇÏ¿© ³ë·ÂÇÏ°í ÀÖÀ½À» È«º¸ÇÏ°í °ü·Ã ¿¬±¸ÀÇ °øÀÍÀû Çʿ伺À» ¾Ë¸± ¼ö ÀÖ´Â °è±â°¡ µÇ¾ú´Ù.


º» ÇÐȸ ù° ³¯¿¡´Â °©»ó¼±ÀýÁ¦¼ú ÈÄ ºÎ°©»ó¼±±â´ÉÀúÇÏÁõÀÇ ¿¹¹æ°ú °ü¸®, °©»ó¼±¾ÏÀÇ ¼ö¼úÀû ÀýÁ¦ ¹üÀ§¿¡ ´ëÇÑ ´Ù¾çÇÑ À̽´µé¿¡ ´ëÇÏ¿© µÎ°³ÀÇ education ¼¼¼ÇÀÌ ÁøÇàµÇ¾úÀ¸¸ç Che-Wei Wu (Kaohsiung Medical University, ENT) ±³¼öÀÇ Special Lecture, ¡°New Technology¸¦ µµÀÔÇÒ ¶§ÀÇ ¸¶À½°¡Áü¡±À̶ó´Â ÁÖÁ¦·Î ±èÁ¤¼ö(°¡Å縯ÀÇ´ë ¿Ü°ú) ±³¼öÀÇ Meet the Professor °­ÀÇ°¡ À̾îÁ³´Ù. ¶ÇÇÑ ¿ÀÈÄ ¼¼¼Ç¿¡¼­´Â Ç×»ó ³í¶õÀÌ µÇ´Â follicular neoplasm ÀÇ Áø´Ü°ú Àå±â ÃßÀû °á°ú¿¡ ´ëÇÑ ÃֽŠ¿¬±¸ °á°ú¿¡ ´ëÇÏ¿© ½ÉÆ÷Áö¾öÀÌ ÀÖ¾ú°í, ¿¬±¸À§¿øȸ ¼¼¼Ç¿¡¼­´Â Ưº°È÷ µðÁöÅÐ ÀÇÇаú °©»ó¼±À̶ó´Â ÁÖÁ¦·Î ´Ù¾çÇÑ °­¿¬°ú Åä·ÐÀÌ À̾îÁ³´Ù. °©»ó¼± ÁúȯÀÇ Áø·á ÇöÀå¿¡¼­ Á¡Á¡ Çö½Ç·Î ´Ù°¡¿À´Â AI ½Ã½ºÅÛ¿¡ ´ëÇÑ ÃֽŠÁö°ßÀ» °øÀ¯ÇÏ°í ¾ÕÀ¸·Î ³ª¾Æ°¥ ¹æÇâ¿¡ ´ëÇØ »ý°¢ÇØ º¼ ¼ö ÀÖ´Â ½Ã°£ÀÌ µÇ¾ú´Ù.

ÇÐȸ µÑ° ³¯¿¡´Â À̸¥ ¿ÀÀüºÎÅÍ ¸¹Àº ûÁßÀÌ ¸ðÀÎ °¡¿îµ¥ ¾Ï¼¼Æ÷ÀÇ clonal history, °©»ó¼±¾ÏÀÇ RET ¹× NTKR Ç¥ÀûÄ¡·á, Cancer Organoids µîÀ» ÁÖÁ¦·Î ÇÑ Èï¹Ì·Î¿î ±âÃÊ ¼¼¼ÇÀ¸·Î ½ÃÀÛÇÏ¿´À¸¸ç ´Ù¾çÇÑ °©»ó¼±, ºÎ°©»óÁúȯ¿¡ ´ëÇÑ ºñ¼ö¼úÀû Ä¡·á ¼¼¼Ç¿¡¼­´Â ¿µ»óÀÇÇаú»Ó ¾Æ´Ï¶ó ³»¿Ü°ú¸¦ ºñ·ÔÇÑ ¸¹Àº ÀÓ»ó°ú¿¡¼­µµ Âü¿©ÇÏ¿© ¿­¶í Åä·ÐÀÌ À̾îÁ³´Ù. Plenary Lecture·Î´Â ÀÌÀü¿¡µµ Çѱ¹À» ã¾Ò´ø Matthew Ringel (The Ohio State University Wexner Medical Center)ÀÇ °­ÀǸ¦ ¿À·£¸¸¿¡ ¿Â¶óÀÎÀ¸·Î Á¢ÇÒ ¼ö ÀÖ¾ú´Ù. °©»ó¼±¾Ï Ç¥ÀûÄ¡·áÀÇ ÃÖ±Ù±îÁöÀÇ µ¿ÇâÀ» Å« È帧À¸·Î °³°ýÇÏ¿´À¸¸ç °­¿¬ Á÷ÈÄ ±¹³» ¿¬±¸Áøµé°úµµ È°¹ßÇÑ ÁúÀÇ ÀÀ´äÀÇ ½Ã°£À» °¡Á³´Ù. À̾ ÁøÇàµÈ Á¤¿õÀ±(¿¬¼¼ÀÇ´ë ¿Ü°ú) ȸÀåÀÇ Presidential Lecture¿¡¼­´Â °©»ó¼± ºÐ¾ßÀÇ ·Îº¿ ¼ö¼úÀÇ °³Ã´Àڷμ­ °É¾î¿Â ¿©Á¤À» °¨µ¿ÀûÀ¸·Î °­¿¬ÇÏ¿© ¸¹Àº ûÁßµéÀÇ °ø°¨ÀÌ ÀÖ¾ú´Ù. ¿ÀÈÄ ¼¼¼Ç¿¡¼­´Â °©»ó¼±¼öÁú¾Ï°ú °ü·ÃÇÑ ÃֽŠ¿¬±¸ °á°ú¿¡ ´ëÇÑ ¼¼¼ÇÀÌ ÀÖ¾ú°í °©»ó¼±ÃÊÀ½ÆÄ ¹× ¹æ»ç¼º¿ä¿Àµå Ä¡·á¿Í °ü·ÃµÈ education ¼¼¼ÇÀÌ À̾îÁ³´Ù. ¶ÇÇÑ À̹ø¿¡ »õ·Î °³Á¤µÇ¾î ¹ßÇ¥µÇ´Â ÀӽŰú °©»ó¼±Áúȯ, °©»ó¼±°áÀý Áø·á±Ç°í¾È¿¡ ´ëÇÑ KTA Áø·áÁöħ °øûȸ°¡ ¸¶Áö¸· ¼ø¼­·Î ÁøÇàµÇ¾î ³¡±îÁö ¿­¶í Åä·ÐÀÇ ºÐÀ§±â¸¦ À̾¸ç ÀÇ°ß ¼ö·ÅÀÇ ±âȸ¸¦ °¡Á³´Ù.





<´ëÇÑ°©»ó¼±ÇÐȸ 2022 Ãß°èÇмú´ëȸ ¼ö»ó ³»¿ª>

±¸ºÐ ¿¬±¸ / ³í¹®Á¦¸ñ ¼º¸í ¼Ò¼Ó
¿ì¼ö ¿¬±¸ÀÚ»ó Precision Medicine for Refractory Thyroid Cancer Patient using Patient-derived 3D Organoid ÀÌ¿ë»ó ¿¬¼¼ÀÇ´ë ¿Ü°ú
ÀþÀº ¿¬±¸ÀÚ»ó Deciphering the role of oncogenes in the rewiring of cancer metabolism ±èÀ¯Çü ¼­¿ïÀÇ´ë ³»°ú
±âÃÊÀÇÇבּ¸»ó Identification of mutation-independent AKT/PKB activation mechanism based on integrated stress response Á¶¿µ¼® ¿¬¼¼ÀÇ´ë ³»°ú
Identifying genomic changes that SARS-CoV-2 infection affects the thyroid gland ÀÌÁø¿í ÀÎÇÏÀÇ´ë ¿Ü°ú
ÃÖ¿ì¼ö³í¹®»ó Clinical Outcome of Fine Needle Aspiration Cytology and Washout Thyroglobulin in Suspicious Lymph Nodes in Differentiated Thyroid Carcinoma: Discordant Results in Real-World Practice ÀÌÁ¤¹Î/ÀÓµ¿ÁØ °¡Å縯ÀÇ´ë ³»°ú
Treatment Effect of Combining Lenvatinib and Vemurafenib for BRAF Mutated Anaplastic Thyroid Cancer ȫä¹®/¾Èº´Ã¶ °æºÏÀÇ´ë ÇÙÀÇÇаú
¿ì¼ö³í¹®»ó Clinical Outcome of Parotid Gland Massage for Preventing Parotid Gland Dysfunction in Patients Treated with Radioiodine Therapy for Differentiated Thyroid Cancer: a Prospective Longitudinal Follow-Up Study ¼Õ½ÂÇö/¾Èº´Ã¶ °æºÏÀÇ´ë ÇÙÀÇÇаú
Clinicopathological Features of Patients Diagnosed with Both Primary Thyroid Cancer and Primary Renal Cell Cancer and Its Comparison with Patients with Thyroid Cancer or Renal Cell Cancer Alone ¹ÚÁØ/±è¼±¿í ¼º±Õ°üÀÇ´ë ³»°ú
Null Association between BRAF V600E Mutation and Tumor Recurrence in Patients with Papillary Thyroid Microcarcinoma in South Korea ±èÁöÀ±/±è°æÁø °í·ÁÀÇ´ë ³»°ú
Serum Carcinoembryonic Antigen as a Biomarker for Medullary Thyroid Cancer ±èÁø¿µ/Á¤ÀçÈÆ ¼º±Õ°üÀÇ´ë ³»°ú
Cooperative Subtype Switch of Thyroid Hormone Receptor and Nuclear Receptor Corepressor Related Epithelial-Mesenchymal Transition in Papillary Thyroid Cancer À̽½±â/ÀÌÀܵð, Á¶¿µ¼® À»ÁöÀÇ´ë ¿Ü°ú/¿¬¼¼ÀÇ´ë ¿Ü°ú, ¿¬¼¼ÀÇ´ë ³»°ú
±¹Á¦ÇÐȸ³í¹®»ó Long term follow-up result of antithyroid drug treatment of Graves hyperthyroidsm in a large cohort ±è¹ÌÈ­ ¿ï»êÀÇ´ë ³»°ú
Lobectomy with central lymph node dissection might be sufficient for low-risk medullary thyroid carcinoma: Who can be a candidate? ¹ÚÇöÁÖ ¼º±Õ°üÀÇ´ë ³»°ú
Monocarboxylate Transporter 4 expression in papillary and anaplastic thyroid carcinoma ±èä¾Æ ¿ï»êÀÇ´ë ³»°ú
Age-associated Mortality is Partially Mediated by TERT Promoter Mutation Status in Differentiated Thyroid Cancer ÇãÁ¤ ¼º±Õ°üÀÇ´ë ³»°ú
Effects of selenium deficiency and excess iodine on maternal thyroid and pregnancy outcome Á¤Àç¿ø ¼­¿ïÀÇ´ë ³»°ú
ÃÖ¿ì¼ö¿¬Á¦»ó Different Metabolic Phenotypes in Thyroid Cancers according to Driver Mutations ±èÀ¯Çü ¼­¿ïÀÇ´ë ³»°ú
Red Blood Cell Extracellular Vesicles-Based Nano-Transporter for Tyrosine Kinase Inhibitor Delivery Exhibits Antitumor Effects in Thyroid Cancer Prakash Gangadaran °æºÏÀÇ´ë ÇÙÀÇÇаú
¿ì¼ö¿¬Á¦»ó Macrofollicular variant of papillary thyroid carcinoma : Ultrasonographic findings and Clinical implication ¿ÀÁöÀ± ¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú
Need for Additional Surgery for Patients diagnosed with Aggressive Variants of Papillary Thyroid Cancer after Lobectomy: A Retrospective Study ÀÌÀÎ¾Æ ¿¬¼¼ÀÇ´ë ¿Ü°ú
Bilateral Axillo-Breast Approach Robotic Thyroidectomy for Graves Disease ±è¿ìö ¼­¿ïÀÇ´ë ¿Ü°ú
Circulating Osteocalcin-Positive Cells as a Novel Biomarker for Bone Metastasis in Thyroid Cancer ¼Û¹Îö ¼­¿ïÀÇ´ë ³»°ú
Preoperative ultrasound parathyroid gland mapping before total thyroidectomy: a preliminary study À±±¤Çö °­¸ª¾Æ»êº´¿ø ¿Ü°ú
Long term follow-up result of antithyroid drug treatment of Graves hyperthyroidism in a large cohort ±è¹ÌÈ­ ¿ï»êÀÇ´ë ³»°ú
¿ì¼öÆ÷½ºÅÍ»ó Low dose radiotherapy can enhances the therapeutic efficacy of immune checkpoint inhibitor in a mouse anaplastic thyroid cancer model ±è´öÀÏ °í·Á´ëÇб³ »ý¸í°úÇкÎ
Metabolic syndrome is associated with the prevalence and incidence of thyroid nodule in adults aged over 50 years; a population-based prospective cohort study °­¼±¿µ À»ÁöÀÇ´ë ³»°ú
Transcriptome profile of thyroid glands and thyroid hormone levels in bile duct ligation mouse model ±èÈñ°æ Àü³²ÀÇ´ë ³»°ú